| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.051 | 0.4 |